BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Clinical Outcome
3 results:

  • 1. Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.
    Eppenberger M; Zlobec I; Baumhoer D; Terracciano L; Lugli A
    BMC Cancer; 2010 Mar; 10():93. PubMed ID: 20222950
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The oncologic benefit of high ligation of the inferior mesenteric artery in the surgical treatment of rectal or sigmoid colon cancer.
    Chin CC; Yeh CY; Tang R; Changchien CR; Huang WS; Wang JY
    Int J Colorectal Dis; 2008 Aug; 23(8):783-8. PubMed ID: 18438677
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Reciprocal regulation of rhoa and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma.
    Bellovin DI; Simpson KJ; Danilov T; Maynard E; Rimm DL; Oettgen P; Mercurio AM
    Oncogene; 2006 Nov; 25(52):6959-67. PubMed ID: 16715134
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.